RxDoctor Payments Data

April Moore, MD

Family Medicine · Forreston, ILNPI 1053523704

Payments from drug & device makers

$1,916in general payments, 2019–2025

Across 111 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$420
  • Boehringer Ingelheim$284
  • GSK$238
  • E.r. Squibb & Sons, L.L.C.$212
  • Pfizer$130
  • Johnson & Johnson$110
  • plus $521 from 12 others

What the payments were for

  • Food & beverage$1,90199%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,916 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$79,081
Medicare patients
232
Services billed
1,393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban152$119,977
JardianceEmpagliflozin107$107,337
XareltoRivaroxaban92$77,556
OzempicSemaglutide83$76,348
RybelsusSemaglutide49$62,948
FarxigaDapagliflozin Propanediol50$49,449
Nurtec OdtRimegepant Sulfate16$34,515
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$20,356
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog51$20,038
TradjentaLinagliptin26$17,164
Tresiba Flextouch U-200Insulin Degludec13$14,554
LinzessLinaclotide15$10,804
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen366$8,877
Advair HfaFluticasone Propion/Salmeterol18$6,768
SymbicortBudesonide/Formoterol Fumarate19$6,673

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$130$154,492168 claims
Novo NordiskOzempic, Rybelsus$94$139,295132 claims
Boehringer IngelheimJardiance, Tradjenta$284$124,501133 claims
Johnson & JohnsonXarelto$110$77,55692 claims
AstraZenecaFarxiga, Symbicort$420$56,12269 claims
GSKTrelegy Ellipta, Arnuity Ellipta$238$23,84541 claims
AbbVieLinzess$103$10,80415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Forreston

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →